Literature DB >> 21084063

Immunomodulatory activity of fucoidan against aspirin-induced gastric mucosal damage in rats.

Hanumantha Rao Balaji Raghavendran1, Periasamy Srinivasan, Sathyanath Rekha.   

Abstract

Gastric ulcers and related complications associated with the use of non-steroidal anti-inflammatory drugs (NSAIDs), such as aspirin, represent a major global health problem. In the present study, we investigate the immunological activity of fucoidan against aspirin-induced gastric mucosal damage in rats. Thirty-six rats were randomly divided into the following, normal (Carboxy methyl cellulose 0.05 %), aspirin (Asp-400mg/kg) treated, fucoidan alone (Fu-0.02 g/kg, daily for 14 days) and Fu+Asp. Cytokines, total nitrite and nitrate (NOx) analysis and tissue localization of Cyclooxygenase 1, 2 and epidermal growth factor receptor (EGFR) were done using Elisa and immunohistochemistry respectively. Histopathology of gastric tissue, collagen deposition was performed using Hematoxylin and Eosin and Masson's trichrome were performed. Treatment of rats with a single dose of aspirin (400mg/kg, orally) led to significant alterations in the levels of total nitrite and nitrate (NOx), interleukins (IL-4, 6, 10, 12), tumor necrosis factor (TNF-α), and interferon gamma (IFN-γ). Notably, collagen deposition in glandular tissue and localization of cyclooxygenase 1, 2, and epidermal growth factor were considerably affected in aspirin-treated rats. These severities were prevented to a significant extent in rats pretreated with fucoidan (0.02 g/kg/day for two weeks orally). Our findings collectively indicate that the gastro-protective effect of fucoidan against aspirin-induced ulceration in rats is mediated through its immunomodulatory properties. Copyright Â
© 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21084063     DOI: 10.1016/j.intimp.2010.11.002

Source DB:  PubMed          Journal:  Int Immunopharmacol        ISSN: 1567-5769            Impact factor:   4.932


  19 in total

1.  Fucoidan enhances intestinal barrier function by upregulating the expression of claudin-1.

Authors:  Atsushi Iraha; Hiroshi Chinen; Akira Hokama; Takumi Yonashiro; Tetsu Kinjo; Kazuto Kishimoto; Manabu Nakamoto; Tetsuo Hirata; Nagisa Kinjo; Futoshi Higa; Masao Tateyama; Fukunori Kinjo; Jiro Fujita
Journal:  World J Gastroenterol       Date:  2013-09-07       Impact factor: 5.742

2.  Silver oxide nanoparticles alleviate indomethacin-induced gastric injury: a novel antiulcer agent.

Authors:  Neveen A Salem; Mohammed A Wahba; Wael H Eisa; Marwa El-Shamarka; Wagdy Khalil
Journal:  Inflammopharmacology       Date:  2017-12-04       Impact factor: 4.473

3.  Protective role of hydrogen-rich water on aspirin-induced gastric mucosal damage in rats.

Authors:  Jing-Yao Zhang; Qi-Fei Wu; Yong Wan; Si-Dong Song; Jia Xu; Xin-Sen Xu; Hu-Lin Chang; Ming-Hui Tai; Ya-Feng Dong; Chang Liu
Journal:  World J Gastroenterol       Date:  2014-02-14       Impact factor: 5.742

Review 4.  Important determinants for fucoidan bioactivity: a critical review of structure-function relations and extraction methods for fucose-containing sulfated polysaccharides from brown seaweeds.

Authors:  Marcel Tutor Ale; Jørn D Mikkelsen; Anne S Meyer
Journal:  Mar Drugs       Date:  2011-10-24       Impact factor: 6.085

Review 5.  Marine polysaccharides from algae with potential biomedical applications.

Authors:  Maria Filomena de Jesus Raposo; Alcina Maria Bernardo de Morais; Rui Manuel Santos Costa de Morais
Journal:  Mar Drugs       Date:  2015-05-15       Impact factor: 5.118

6.  Structure of fucoidan from brown seaweed Turbinaria ornata as studied by electrospray ionization mass spectrometry (ESIMS) and small angle X-ray scattering (SAXS) techniques.

Authors:  Thuy Thi Thu Thanh; Van Thi Thanh Tran; Yoshiaki Yuguchi; Ly Minh Bui; Tai Tien Nguyen
Journal:  Mar Drugs       Date:  2013-07-12       Impact factor: 5.118

Review 7.  Sulfated Seaweed Polysaccharides as Multifunctional Materials in Drug Delivery Applications.

Authors:  Ludmylla Cunha; Ana Grenha
Journal:  Mar Drugs       Date:  2016-02-25       Impact factor: 5.118

8.  Low-molecular-weight fucoidan and high-stability fucoxanthin from brown seaweed exert prebiotics and anti-inflammatory activities in Caco-2 cells.

Authors:  Pai-An Hwang; Nam Nhut Phan; Wen-Jung Lu; Bui Thi Ngoc Hieu; Yen-Chang Lin
Journal:  Food Nutr Res       Date:  2016-08-02       Impact factor: 3.894

Review 9.  Fucoidan as a marine anticancer agent in preclinical development.

Authors:  Jong-Young Kwak
Journal:  Mar Drugs       Date:  2014-01-28       Impact factor: 5.118

10.  Pretreatment with Fucoidan from Fucus vesiculosus Protected against ConA-Induced Acute Liver Injury by Inhibiting Both Intrinsic and Extrinsic Apoptosis.

Authors:  Jingjing Li; Kan Chen; Sainan Li; Tong Liu; Fan Wang; Yujing Xia; Jie Lu; Yingqun Zhou; Chuanyong Guo
Journal:  PLoS One       Date:  2016-04-01       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.